BETTER THERAPEUTICS (MCADR) Stock Price, News & Analysis

MCADR

Company Description

This page collects what Stock Titan holds for MCADR, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—

0.00%

0.00

Last updated:

-

Performance 1 year

$0.0

7.6M

Shares outstanding

Latest News

March 15, 2021

—

Mountain Crest Acquisition Corp. II Announces that Common Stock and Rights to Commence Separate Trading on or about March 17, 2021

acquisition

January 14, 2021

—

Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering

IPO offering acquisition

January 12, 2021

—

Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering

IPO offering acquisition

January 7, 2021

—

Mountain Crest Acquisition Corp. II Announces Pricing of $50 Million Initial Public Offering

IPO offering acquisition

BETTER THERAPEUTICS has 4 recent news articles. Key topics include acquisition, IPO, offering. View all MCADR news →

SEC Filings

No SEC filings available for MCADR.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months